Enrolling by invitationNot applicableNCT07217249
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
Studying Corneal dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Western Reserve University
- Principal Investigator
- Jonathan Lass, MDCase Western Reserve University
- Intervention
- Descemet membrane endothelial keratoplasty(procedure)
- Enrollment
- 570 enrolled
- Eligibility
- 30-93 years · All sexes
- Timeline
- 2025 – 2030
Study locations (14)
- Georgia Eye Partners, Atlanta, Georgia, United States
- Price Vision Group, Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- Kansas City Eye Clinic, Overland Park, Kansas, United States
- Mid-Atlantic Cornea Consultants, Baltimore, Maryland, United States
- The Wilmer Eye Institute/Johns Hopkins, Baltimore, Maryland, United States
- University of Michigan/Kellogg Eye Center, Ann Arbor, Michigan, United States
- Verdier Eye Center, Grand Rapids, Michigan, United States
- Minnesota Eye Consultants, Bloomington, Minnesota, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Associated Eye Care, Stillwater, Minnesota, United States
- Moyes Eye Center, Kansas City, Missouri, United States
- Legacy Devers Eye Institute, Portland, Oregon, United States
- Ophthalmic Partners, Bala-Cynwyd, Pennsylvania, United States
Collaborators
National Eye Institute (NEI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07217249 on ClinicalTrials.govOther trials for Corneal dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07373821Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)University Hospital Heidelberg
- RECRUITINGPHASE2NCT07024693DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal DystrophyDesign Therapeutics, Inc.
- RECRUITINGNANCT06844123Microsurgical Robot-assisted Corneal TransplantCHU de Reims
- RECRUITINGNANCT06425666Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal DystrophyUniversity of Cologne
- RECRUITINGNCT06966167Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With CataractsEye & ENT Hospital of Fudan University
- RECRUITINGNCT06859411Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort StudyCentre Hospitalier Régional Metz-Thionville
- RECRUITINGPHASE3NCT05275972Descemet Endothelial Thickness Comparison Trial IIStanford University
- RECRUITINGPHASE2NCT04440280Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal DystrophyMassachusetts Eye and Ear Infirmary